Antiviral therapy for HCV using direct acting antiviral drugs in patients with chronic hepatitis C undergoing hemodialysis.
Not Applicable
Recruiting
- Conditions
- Patients with HCV genotype 1B infection who are undergoing maintenance hemodialysis.
- Registration Number
- JPRN-UMIN000017023
- Lead Sponsor
- Ogaki Municipal Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
Patients infected with HCV other than HCV genotype 1B. Patients with Child-Pugh class B or C cirrhosis.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Antiviral efficacy to eradicate HCV in patients with chronic HCV infection undergoing hemodialysis.
- Secondary Outcome Measures
Name Time Method Safety of oral antiviral therapy in patients with chronic HCV infection undergoing hemodialysis.